Evaluation Of Cardiovascular Health Outcomes Among Survivors 2
Recruiting now · Not applicable
Conditions studied: Health Behavior
In brief
Childhood cancer survivors who received certain treatments are at a higher risk of developing heart problems in the future. This study is looking at ways to educate childhood cancer survivors about that risk and encourage them to receive a recommended heart screening test.
Key facts
- Study ID
- NCT07245420
- Run by
- St. Jude Children's Research Hospital
- People needed
- 350
- Starts
- 2026-09-01
- Expected to finish
- 2030-12-01
- Last updated by the study team
- 2026-06-26
Who can join
Age: 26 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Childhood Cancer Survivor Study (CCSS) Participants
- Age ≥26 years
- Treated with cumulative doxorubicin equivalent anthracycline doses ≥100 mg/m2 with any/no radiation, or ≥15 Gy chest radiation with any/no anthracyclines
- No history of cardiomyopathy
- Has not had an echocardiogram in the previous 5 years
- Has a history of successful completion of CCSS surveys
- English-Speaking
- Has not been enrolled in ECHOS-1 (pilot)
You may not qualify if…
- Currently participating in a long-term follow-up program that provides risk-based screening
Where it is running
- St. Jude Children's Research Hospital — Memphis, Tennessee, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.